COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND BIOLOGICS AS INDUCTION THERAPY FOR MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

著录项

• 来源
  《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2017年第5期|共1页
• 作者

  Rubin D. T.; Ashaye A. O.; Zhang Y.; Xu Y.; Fahrbach K.; Chen L. A.; Manuchehri A.; Kayhan C.; Woolcott J. C.; Cappelleri J. C.; Healey P.;

  展开▼
• 作者单位

  Univ Chicago Med Chicago IL USA;

  Evidera Inc Waltham MA USA;

  Evidera London England;

  Evidera Inc Waltham MA USA;

  Evidera Inc Waltham MA USA;

  NYU Langone Med Ctr New York NY USA;

  Pfizer Ltd Tadworth England;

  Pfizer Inc Collegeville PA USA;

  Pfizer Canada Inc Kirkland PQ Canada;

  Pfizer Inc Groton CT 06340 USA;

  Pfizer Inc Groton CT 06340 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 预防医学、卫生学;
• 关键词